SERPINB2 and lung carcinoma: The SerpinB2-deficient human lung cancer cell line H2030-BrM3 and human breast cancer cell line MDA231-BrM2 do not form brain metastases because the deleterious effects of SerpinB2 on the vascular attachment and survival of cancer cells are inhibited [19].